PGC-1 α induction in pulmonary arterial hypertension

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Mata, Manuel ^a,b   Sarrion, Irene ^a   Milian, Lara ^c   Juan, Gustavo ^a,c   Ramon, Mercedes ^a   Naufal, Dolores ^a   Gil, Juan ^d   Ridocci, F ^a   Fabregat Andres O ^a   Cortijo, Julio ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL PRESSURES; BLOOD SAMPLES; CYTOCHROME C; EXPRESSION LEVELS; GLUTATHIONE PEROXIDASE; HEART FAILURE; MITOCHONDRIAL BIOGENESIS; MRNA LEVEL; NEGATIVE CORRELATION; OXIDATIVE METABOLISM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; POSITIVE CORRELATIONS; PULMONARY ARTERIAL HYPERTENSION; PULMONARY ARTERY; SUPEROXIDE DISMUTASES; TOTAL ANTIOXIDANT STATUS;

CYTOLOGY;

OXYGEN;

CYTOCHROME C; GLUTATHIONE PEROXIDASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SUPEROXIDE DISMUTASE; CHLORIDE; HEAT SHOCK PROTEIN; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOXIA; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OXYGEN TENSION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; AGE; BLOOD; CHEMISTRY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; VASCULAR RESISTANCE;

ADULT; AGE FACTORS; AGED; CHLORIDES; CYTOCHROMES C; FEMALE; GLUTATHIONE PEROXIDASE; HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS; VASCULAR RESISTANCE;

EID: 84866148175     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/236572     Document Type: Article

References (34)

1. Rich S., Dantzker D. R., Ayres S. M., Primary pulmonary hypertension. A national prospective study. Annals of Internal Medicine 1987 107 2 216 223 (Pubitemid 17137857)
2. McLaughlin V. V., Archer S. L., Badesch D. B., Barst R. J., Farber H. W., Lindner J. R., Mathier M. A., McGoon M. D., Park M. H., Rosenson R. S., Rubin L. J., Tapson V. F., Varga J., ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009 119 16 2250 2294
3. Galiè N., Hoeper M. M., Humbert M., Torbicki A., Vachiery J. L., Barbera J. A., Beghetti M., Corris P., Gaine S., Gibbs J. S., Gomez-Sanchez M. A., Jondeau G., Klepetko W., Opitz C., Peacock A., Rubin L., Zellweger M., Simonneau G., Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal 2009 34 6 1219 1263 2-s2.0-70349634397 10.1183/09031936.00139009
4. D'Alonzo G. E., Barst R. J., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., Fishman A. P., Goldring R. M., Groves B. M., Kernis J. T., Levy P. S., Pietra G. G., Reid L. M., Reeves J. T., Rich S., Vreim C. E., Williams G. W., Wu M., Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Annals of Internal Medicine 1991 115 5 343 349 2-s2.0-0025837793
5. Bristow M. R., Minobe W., Rasmussen R., Larrabee P., Skerl L., Klein J. W., Anderson F. L., Murray J., Mestroni L., Karwande S. V., Fowler M., Ginsburg R., β -adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. Journal of Clinical Investigation 1992 89 3 803 815 2-s2.0-0026547854
6. Mouchaers K. T. B., Schalij I., Versteilen A. M. G., Hadi A. M., Van Nieuw Amerongen G. P., Van Hinsbergh V. W. M., Postmus P. E., Van Der Laarse W. J., Vonk-Noordegraaf A., Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension. American Journal of Physiology 2009 297 1 H200 H207 2-s2.0-67650069940 10.1152/ajpheart.00893.2008
7. Des Tombe A. L., Van Beek-Harmsen B. J., Lee-De Groot M. B. E., Van Der Laarse W. J., Calibrated histochemistry applied to oxygen supply and demand in hypertrophied rat myocardium. Microscopy Research and Technique 2002 58 5 412 420 2-s2.0-0036727167 10.1002/jemt.10153 (Pubitemid 34983280)
8. Zong P., Tune J. D., Downey H. F., Mechanisms of oxygen demand/supply balance in the right ventricle. Experimental Biology and Medicine 2005 230 8 507 519 2-s2.0-24144502875 (Pubitemid 41233149)
9. Sano M., Minamino T., Toko H., Miyauchi H., Orimo M., Qin Y., Akazawa H., Tateno K., Kayama Y., Harada M., Shimizu I., Asahara T., Hamada H., Tomita S., Molkentin J. D., Zou Y., Komuro I., p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007 446 7134 444 448 2-s2.0-33947520124 10.1038/nature05602 (Pubitemid 46474597)
10. Voelkel N. F., Quaife R. A., Leinwand L. A., Barst R. J., McGoon M. D., Meldrum D. R., Dupuis J., Long C. S., Rubin L. J., Smart F. W., Suzuki Y. J., Gladwin M., Denholm E. M., Gail D. B., Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006 114 17 1883 1891 2-s2.0-33750560212 10.1161/CIRCULATIONAHA.106.632208 (Pubitemid 44673364)
11. Hoshikawa Y., Ono S., Suzuki S., Tanita T., Chida M., Song C., Noda M., Tabata T., Voelkel N. F., Fujimura S., Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. Journal of Applied Physiology 2001 90 4 1299 1306 2-s2.0-0035100461 (Pubitemid 32220912)
12. Liu J. Q., Zelko I. N., Erbynn E. M., Sham J. S. K., Folz R. J., Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). American Journal of Physiology 2006 290 1 L2 L10 2-s2.0-33644798841 10.1152/ajplung.00135.2005
13. Lakshminrusimha S., Russell J. A., Wedgwood S., Gugino S. F., Kazzaz J. A., Davis J. M., Steinhorn R. H., Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2006 174 12 1370 1377 2-s2.0-33845478939 10.1164/rccm.200605-676OC (Pubitemid 44913039)
14. Ahmed M. N., Suliman H. B., Folz R. J., Nozik-Grayck E., Golson M. L., Mason S. N., Auten R. L., Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice. American Journal of Respiratory and Critical Care Medicine 2003 167 3 400 405 2-s2.0-0037320049 10.1164/rccm.200202-108OC (Pubitemid 36216423)
15. Elmedal B., de Dam M. Y., Mulvany M. J., Simonsen U., The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. British Journal of Pharmacology 2004 141 1 105 113 2-s2.0-1242318713 10.1038/sj.bjp.0705580 (Pubitemid 38241168)
16. Leopold J. A., Redox pioneer: Professor Joseph Loscalzo. Antioxidants & Redox Signaling 2010 13 7 1125 1132 2-s2.0-79952199797
17. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R. C., Spiegelman B. M., Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999 98 1 115 124 2-s2.0-0033538473 10.1016/S0092- 8674(00)80611-X (Pubitemid 29331201)
18. Ding L., Liang X., Zhu D., Lou Y., Peroxisome proliferator-activated receptor α is involved in cardiomyocyte differentiation of murine embryonic stem cells in vitro. Cell Biology International 2007 31 9 1002 1009 2-s2.0-34249318044 10.1016/j.cellbi.2007.03.013 (Pubitemid 46819073)
19. Honda T., Kaikita K., Tsujita K., Hayasaki T., Matsukawa M., Fuchigami S., Sugiyama S., Sakashita N., Ogawa H., Takeya M., Pioglitazone, a peroxisome proliferator-activated receptor- γ agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders. Journal of Molecular and Cellular Cardiology 2008 44 5 915 926 2-s2.0-42749092253 10.1016/j.yjmcc.2008.03.004
20. Shiomi T., Tsutsui H., Hayashidani S., Suematsu N., Ikeuchi M., Wen J., Ishibashi M., Kubota T., Egashira K., Takeshita A., Pioglitazone, a peroxisome proliferator-activated receptor- γ agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002 106 24 3126 3132 2-s2.0-0037058874 10.1161/01.CIR.0000039346.31538.2C (Pubitemid 35440299)
21. Yue T. L., Chen J., Bao W., Narayanan P. K., Bril A., Jiang W., Lysko P. G., Gu J. L., Boyce R., Zimmerman D. M., Hart T. K., Buckingham R. E., Ohlstein E. H., In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor- γ agonist rosiglitazone. Circulation 2001 104 21 2588 2594 2-s2.0-0035923566 (Pubitemid 33104798)
22. Fabregat-Andrés Ó., Tierrez A., Mata M., Estornell-Erill J., Ridocci-Soriano F., Monsalve M., Induction of PGC-1á expression can be detected in blood samples of patients with ST-segment elevation acute myocardial infarction. PLoS ONE 2011 6 11 e26913
23. Mata M., Sarriá B., Buenestado A., Cortijo J., Cerdá M., Morcillo E. J., Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells. Thorax 2005 60 2 144 152 2-s2.0-13544273183 10.1136/thx.2004.025692 (Pubitemid 40222898)
24. Casanova C., Celli B. R., Barria P., Casas A., Cote C., De Torres J. P., Jardim J., Lopez M. V., Marin J. M., Montes De Oca M., Pinto-Plata V., Aguirre-Jaime A., The 6-min walk distance in healthy subjects: reference standards from seven countries. European Respiratory Journal 2011 37 1 150 156 2-s2.0-79251535882 10.1183/09031936.00194909
25. Calvo J. A., Daniels T. G., Wang X., Paul A., Lin J., Spiegelman B. M., Stevenson S. C., Rangwala S. M., Muscle-specific expression of PPAR γ coactivator-1 α improves exercise performance and increases peak oxygen uptake. Journal of Applied Physiology 2008 104 5 1304 1312 2-s2.0-45149108625 10.1152/japplphysiol.01231.2007
26. Lin J., Wu H., Tarr P. T., Zhang C. Y., Wu Z., Boss O., Michael L. F., Puigserver P., Isotani E., Olson E. N., Lowell B. B., Bassel-Duby R., Spiegelman B. M., Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibres. Nature 2002 418 6899 797 801 2-s2.0-0037102256 10.1038/nature00904
27. Leick L., Fentz J., Bienso R. S., Knudsen J. G., Jeppesen J., Kiens B., Wojtaszewski J. F. P., Pilegaard H., PGC-1 α is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. American Journal of Physiology 2010 299 3 E456 E465 2-s2.0-77956802137 10.1152/ajpendo.00648.2009
28. Nozik-Grayck E., Suliman H. B., Majka S., Albietz J., Van Rheen Z., Roush K., Stenmark K. R., Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. American Journal of Physiology 2008 295 3 L422 L430 2-s2.0-52649119390 10.1152/ajplung.90293.2008
29. Ahmed M. N., Zhang Y., Codipilly C., Zaghloul N., Patel D., Wolin M., Miller E. J., Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension. Molecular Medicine 2012 18 1 38 46 10.2119/molmed.2011.00339
30. Masri F. A., Comhair S. A. A., Dostanic-Larson I., Kaneko F. T., Dweik R. A., Arroliga A. C., Erzurum S. C., Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clinical and Translational Science 2008 1 2 99 106 2-s2.0-77749302055 10.1111/j.1752-8062.2008.00035.x
31. Milara J., Gabarda E., Juan G., Ortiz J. L., Guijarro R., Martorell M., Morcillo E. J., Cortijo J., Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries. European Respiratory Journal 2012 39 4 927 938
32. Milara J., Ortiz J. L., Juan G., Guijarro R., Almudever P., Martorell M., Morcillo E. J., Cortijo J., Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences. British Journal of Pharmacology 2010 161 7 1599 1615 2-s2.0-78149376148 10.1111/j.1476-5381.2010.00979.x
33. Milara J., Juan G., Ortiz J. L., Guijarro R., Losada M., Serrano A., Morcillo E. J., Cortijo J., Cigarette smoke-induced pulmonary endothelial dysfunction is partially suppressed by sildenafil. European Journal of Pharmaceutical Sciences 2010 39 5 363 372 2-s2.0-77549083365 10.1016/j.ejps.2010.01.005
34. Rudarakanchana N., Trembath R.C., Morrell N.W., New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax 2001 56 11 888-890 2-s2.0-0034778362 10.1136/thorax.56.11.888. (Pubitemid 32999839)